Buyout Desk
Platform

Bertram Capital acquires Medical Technology Associates from Riverarch

Pinellas Park, Florida-based provider of compliance testing, inspection and calibration services to healthcare and life sciences customers; terms not disclosed.

Target
Medical Technology Associates
Buyer
Bertram Capital
Status
Completed

Bertram Capital has announced its investment in Medical Technology Associates, a provider of regulatory-driven compliance services to healthcare and life sciences customers. Bertram acquired the company from Riverarch Equity Partners, which had acquired it in 2022. Terms were not disclosed. The deal is Bertram's eighth platform investment in its Fund V.

Headquartered in Pinellas Park, Florida, MTA employs more than 150 technicians serving hospitals, health systems, pharmacies and laboratories nationwide. It offers testing, inspection, certification, repair and replacement services across medical gas, controlled environment, calibration, biomedical and laboratory testing. Allan Morris will remain chief executive, and the existing leadership team will retain meaningful ownership.

Jared Ruger, a partner at Bertram, said MTA's breadth of services lets it serve customers as one partner across their compliance needs. Houlihan Lokey advised the seller, while Intrepid Investment Bankers and Hirschler advised Bertram. Golub Capital and BTG Pactual Strategic Capital provided financing.

Background

Business
Provider of testing, inspection, certification, repair and calibration services to healthcare and life sciences customers
Deal type
Platform
Headquarters
Pinellas Park, Florida
Advisers
  • Houlihan Lokey sell-side financial adviser to Medical Technology Associates
  • Intrepid Investment Bankers buy-side financial adviser to Bertram Capital
  • Hirschler legal counsel to Bertram Capital
  • Golub Capital financing provider
  • BTG Pactual Strategic Capital financing provider

Sources

Written by Buyout Desk from the sources above. Spotted an error? Email corrections@buyoutdesk.com.

Bertram Capital deal history